BR100 Increased By (0.07%)
BR30 Increased By (0.02%)
KSE100 Increased By (0.27%)
KSE30 Increased By (0.1%)
AGHA 7.60 Decreased By ▼ -0.03 (-0.39%)
BECO 5.55 Decreased By ▼ -0.02 (-0.36%)
BML 59.95 Increased By ▲ 0.21 (0.35%)
BOP 34.78 Increased By ▲ 0.38 (1.1%)
CNERGY 12.79 Decreased By ▼ -0.32 (-2.44%)
CSIL 6.46 Increased By ▲ 0.05 (0.78%)
FCCL 57.70 Decreased By ▼ -0.36 (-0.62%)
FFL 16.30 Increased By ▲ 0.07 (0.43%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 7.44 Increased By ▲ 0.01 (0.13%)
KOSM 6.12 Increased By ▲ 0.09 (1.49%)
LOTCHEM 27.75 Increased By ▲ 0.08 (0.29%)
MLCF 102.36 Decreased By ▼ -0.39 (-0.38%)
NBP 205.64 Increased By ▲ 0.58 (0.28%)
NCPL 60.18 Increased By ▲ 0.55 (0.92%)
NPL 69.10 Increased By ▲ 0.54 (0.79%)
OGDC 318.60 Decreased By ▼ -0.32 (-0.1%)
PACE 11.15 Increased By ▲ 0.10 (0.9%)
PAEL 43.20 Increased By ▲ 0.10 (0.23%)
PIBTL 16.74 Increased By ▲ 0.11 (0.66%)
PPL 229.05 Decreased By ▼ -0.40 (-0.17%)
PRL 69.01 Decreased By ▼ -1.79 (-2.53%)
PTC 71.02 Increased By ▲ 0.02 (0.03%)
SSGC 27.48 Increased By ▲ 0.07 (0.26%)
TBL 10.34 Increased By ▲ 0.03 (0.29%)
TELE 8.58 Increased By ▲ 0.05 (0.59%)
TPL 23.30 Increased By ▲ 0.24 (1.04%)
TPLP 15.76 No Change ▼ 0.00 (0%)
TREET 24.98 Increased By ▲ 0.27 (1.09%)
TRG 60.45 Increased By ▲ 0.16 (0.27%)
By

MUMBAI: The Indian rupee is expected to open slightly weaker on Friday, with traders expecting the currency to hold a depreciation bias in the near term amid worries over the impact of steep U.S. tariffs on Indian exports and persistent portfolio outflows.

The 1-month non-deliverable forward indicated the rupee will open in the 87.65-87.70 range versus the U.S. dollar, compared with 87.5950 in the previous session.

The rupee declined about 2% in July, with U.S. President Donald Trump’s threat of a 25% levy on Indian goods, alongside an unspecified penalty, pushing it closer to its all-time low of 87.95.

Economists estimate that the 25% tariff announced could shave off the South Asian nation’s growth in 2025-26 by up to 40 basis points, but analysts and investors also reckon that India may be able to achieve a lower rate via negotiations.

“India remains a strategic partner for the U.S. and stands to benefit from opening up its large market. We, therefore, believe there is a path forward and expect India will eventually secure a relatively favourable deal,” analysts at BMI said in a note.

A tariff on pharmaceutical exports from India, if implemented, would have a more serious impact on India’s growth, the note added.

Uncertainty on trade is also expected to be a near-term drag on foreign investors’ outlook on Indian equities. Overseas investors net pulled out over $600 million from local stocks on Thursday, per provisional exchange data.

The 25% tariff may mark the beginning of protracted negotiation, but “India needs some positive news to grab foreign investors’ interest as they have continued to dump Indian equities and North Asia, with its value, income and reform tilt is faring much more strongly,” said Sat Dhura, portfolio manager at Janus Henderson Investors.

“It will take more than a trade announcement to reverse that,” Dhura said.

Meanwhile, Asian currencies were down between 0.1% and 0.5% on the day, while slimmed hopes of a rate cut by the U.S. Federal Reserve in September helped the dollar cling to the 100 handle, its highest in about two months.

Comments

Comments are closed for this article.